nodes	percent_of_prediction	percent_of_DWPC	metapath
Ceftaroline fosamil—Diarrhoea—Pazopanib—kidney cancer	0.00247	0.00247	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.00247	0.00247	CcSEcCtD
Ceftaroline fosamil—Renal failure—Paclitaxel—kidney cancer	0.00247	0.00247	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Everolimus—kidney cancer	0.00246	0.00246	CcSEcCtD
Ceftaroline fosamil—Pain—Vinblastine—kidney cancer	0.00245	0.00245	CcSEcCtD
Ceftaroline fosamil—Constipation—Vinblastine—kidney cancer	0.00245	0.00245	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Gemcitabine—kidney cancer	0.00244	0.00244	CcSEcCtD
Ceftaroline fosamil—Pain—Everolimus—kidney cancer	0.00244	0.00244	CcSEcCtD
Ceftaroline fosamil—Constipation—Everolimus—kidney cancer	0.00244	0.00244	CcSEcCtD
Ceftaroline fosamil—Vomiting—Temsirolimus—kidney cancer	0.00244	0.00244	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Capecitabine—kidney cancer	0.00243	0.00243	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Gemcitabine—kidney cancer	0.00243	0.00243	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Sorafenib—kidney cancer	0.00243	0.00243	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Sorafenib—kidney cancer	0.00242	0.00242	CcSEcCtD
Ceftaroline fosamil—Rash—Temsirolimus—kidney cancer	0.00242	0.00242	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Temsirolimus—kidney cancer	0.00241	0.00241	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Sorafenib—kidney cancer	0.0024	0.0024	CcSEcCtD
Ceftaroline fosamil—Headache—Temsirolimus—kidney cancer	0.0024	0.0024	CcSEcCtD
Ceftaroline fosamil—Dizziness—Pazopanib—kidney cancer	0.00239	0.00239	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00237	0.00237	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Paclitaxel—kidney cancer	0.00237	0.00237	CcSEcCtD
Ceftaroline fosamil—Pain—Erlotinib—kidney cancer	0.00235	0.00235	CcSEcCtD
Ceftaroline fosamil—Constipation—Erlotinib—kidney cancer	0.00235	0.00235	CcSEcCtD
Ceftaroline fosamil—Erythema—Gemcitabine—kidney cancer	0.00234	0.00234	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Vinblastine—kidney cancer	0.00234	0.00234	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Sunitinib—kidney cancer	0.00233	0.00233	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Sunitinib—kidney cancer	0.00233	0.00233	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Everolimus—kidney cancer	0.00233	0.00233	CcSEcCtD
Ceftaroline fosamil—Hyperkalaemia—Doxorubicin—kidney cancer	0.00233	0.00233	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Sunitinib—kidney cancer	0.00231	0.00231	CcSEcCtD
Ceftaroline fosamil—Vomiting—Pazopanib—kidney cancer	0.0023	0.0023	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Paclitaxel—kidney cancer	0.00229	0.00229	CcSEcCtD
Ceftaroline fosamil—Anaemia—Vincristine—kidney cancer	0.00228	0.00228	CcSEcCtD
Ceftaroline fosamil—Rash—Pazopanib—kidney cancer	0.00228	0.00228	CcSEcCtD
Ceftaroline fosamil—Nausea—Temsirolimus—kidney cancer	0.00228	0.00228	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Pazopanib—kidney cancer	0.00227	0.00227	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Vinblastine—kidney cancer	0.00226	0.00226	CcSEcCtD
Ceftaroline fosamil—Headache—Pazopanib—kidney cancer	0.00226	0.00226	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Everolimus—kidney cancer	0.00225	0.00225	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Everolimus—kidney cancer	0.00225	0.00225	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Erlotinib—kidney cancer	0.00225	0.00225	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Paclitaxel—kidney cancer	0.00222	0.00222	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Paclitaxel—kidney cancer	0.00221	0.00221	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Dactinomycin—kidney cancer	0.00221	0.00221	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Erlotinib—kidney cancer	0.00217	0.00217	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Erlotinib—kidney cancer	0.00217	0.00217	CcSEcCtD
Ceftaroline fosamil—Anaemia—Gemcitabine—kidney cancer	0.00216	0.00216	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Capecitabine—kidney cancer	0.00216	0.00216	CcSEcCtD
Ceftaroline fosamil—Nausea—Pazopanib—kidney cancer	0.00214	0.00214	CcSEcCtD
Ceftaroline fosamil—Convulsion—Vincristine—kidney cancer	0.00214	0.00214	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Sorafenib—kidney cancer	0.00214	0.00214	CcSEcCtD
Ceftaroline fosamil—Pain—Sorafenib—kidney cancer	0.00212	0.00212	CcSEcCtD
Ceftaroline fosamil—Constipation—Sorafenib—kidney cancer	0.00212	0.00212	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Vinblastine—kidney cancer	0.00211	0.00211	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Everolimus—kidney cancer	0.0021	0.0021	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Capecitabine—kidney cancer	0.00208	0.00208	CcSEcCtD
Ceftaroline fosamil—Infestation—Capecitabine—kidney cancer	0.00206	0.00206	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Capecitabine—kidney cancer	0.00206	0.00206	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00206	0.00206	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Paclitaxel—kidney cancer	0.00204	0.00204	CcSEcCtD
Ceftaroline fosamil—Pain—Sunitinib—kidney cancer	0.00204	0.00204	CcSEcCtD
Ceftaroline fosamil—Constipation—Sunitinib—kidney cancer	0.00204	0.00204	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Paclitaxel—kidney cancer	0.00203	0.00203	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Sorafenib—kidney cancer	0.00202	0.00202	CcSEcCtD
Ceftaroline fosamil—Renal failure—Capecitabine—kidney cancer	0.00202	0.00202	CcSEcCtD
Ceftaroline fosamil—Pruritus—Everolimus—kidney cancer	0.00202	0.00202	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Vincristine—kidney cancer	0.00201	0.00201	CcSEcCtD
Ceftaroline fosamil—Phlebitis—Doxorubicin—kidney cancer	0.002	0.002	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.00198	0.00198	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Vincristine—kidney cancer	0.00197	0.00197	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Vincristine—kidney cancer	0.00197	0.00197	CcSEcCtD
Ceftaroline fosamil—Urticaria—Sorafenib—kidney cancer	0.00197	0.00197	CcSEcCtD
Ceftaroline fosamil—Erythema—Paclitaxel—kidney cancer	0.00196	0.00196	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Paclitaxel—kidney cancer	0.00196	0.00196	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Vinblastine—kidney cancer	0.00196	0.00196	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Sorafenib—kidney cancer	0.00196	0.00196	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Sorafenib—kidney cancer	0.00196	0.00196	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Everolimus—kidney cancer	0.00195	0.00195	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Sunitinib—kidney cancer	0.00195	0.00195	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Capecitabine—kidney cancer	0.00195	0.00195	CcSEcCtD
Ceftaroline fosamil—Pruritus—Erlotinib—kidney cancer	0.00195	0.00195	CcSEcCtD
Ceftaroline fosamil—Pain—Dactinomycin—kidney cancer	0.00193	0.00193	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Gemcitabine—kidney cancer	0.00191	0.00191	CcSEcCtD
Ceftaroline fosamil—Dizziness—Vinblastine—kidney cancer	0.00189	0.00189	CcSEcCtD
Ceftaroline fosamil—Dizziness—Everolimus—kidney cancer	0.00188	0.00188	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Sunitinib—kidney cancer	0.00188	0.00188	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Sunitinib—kidney cancer	0.00188	0.00188	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Erlotinib—kidney cancer	0.00188	0.00188	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Capecitabine—kidney cancer	0.00188	0.00188	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Gemcitabine—kidney cancer	0.00187	0.00187	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Gemcitabine—kidney cancer	0.00187	0.00187	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Gemcitabine—kidney cancer	0.00186	0.00186	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Capecitabine—kidney cancer	0.00185	0.00185	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Dactinomycin—kidney cancer	0.00184	0.00184	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Capecitabine—kidney cancer	0.00182	0.00182	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Sorafenib—kidney cancer	0.00182	0.00182	CcSEcCtD
Ceftaroline fosamil—Vomiting—Vinblastine—kidney cancer	0.00182	0.00182	CcSEcCtD
Ceftaroline fosamil—Dizziness—Erlotinib—kidney cancer	0.00182	0.00182	CcSEcCtD
Ceftaroline fosamil—Vomiting—Everolimus—kidney cancer	0.00181	0.00181	CcSEcCtD
Ceftaroline fosamil—Anaemia—Paclitaxel—kidney cancer	0.00181	0.00181	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Capecitabine—kidney cancer	0.00181	0.00181	CcSEcCtD
Ceftaroline fosamil—Rash—Everolimus—kidney cancer	0.0018	0.0018	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Everolimus—kidney cancer	0.0018	0.0018	CcSEcCtD
Ceftaroline fosamil—Headache—Vinblastine—kidney cancer	0.00179	0.00179	CcSEcCtD
Ceftaroline fosamil—Headache—Everolimus—kidney cancer	0.00179	0.00179	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Dactinomycin—kidney cancer	0.00178	0.00178	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Dactinomycin—kidney cancer	0.00178	0.00178	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Sunitinib—kidney cancer	0.00175	0.00175	CcSEcCtD
Ceftaroline fosamil—Pruritus—Sorafenib—kidney cancer	0.00175	0.00175	CcSEcCtD
Ceftaroline fosamil—Vomiting—Erlotinib—kidney cancer	0.00175	0.00175	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Vincristine—kidney cancer	0.00174	0.00174	CcSEcCtD
Ceftaroline fosamil—Rash—Erlotinib—kidney cancer	0.00173	0.00173	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Erlotinib—kidney cancer	0.00173	0.00173	CcSEcCtD
Ceftaroline fosamil—Palpitations—Paclitaxel—kidney cancer	0.00173	0.00173	CcSEcCtD
Ceftaroline fosamil—Headache—Erlotinib—kidney cancer	0.00172	0.00172	CcSEcCtD
Ceftaroline fosamil—Pain—Vincristine—kidney cancer	0.00172	0.00172	CcSEcCtD
Ceftaroline fosamil—Constipation—Vincristine—kidney cancer	0.00172	0.00172	CcSEcCtD
Ceftaroline fosamil—Nausea—Vinblastine—kidney cancer	0.0017	0.0017	CcSEcCtD
Ceftaroline fosamil—Convulsion—Paclitaxel—kidney cancer	0.0017	0.0017	CcSEcCtD
Ceftaroline fosamil—Nausea—Everolimus—kidney cancer	0.00169	0.00169	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Sorafenib—kidney cancer	0.00169	0.00169	CcSEcCtD
Ceftaroline fosamil—Pruritus—Sunitinib—kidney cancer	0.00168	0.00168	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Capecitabine—kidney cancer	0.00168	0.00168	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Capecitabine—kidney cancer	0.00167	0.00167	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Dactinomycin—kidney cancer	0.00166	0.00166	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.00166	0.00166	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.00165	0.00165	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Vincristine—kidney cancer	0.00165	0.00165	CcSEcCtD
Ceftaroline fosamil—Dizziness—Sorafenib—kidney cancer	0.00164	0.00164	CcSEcCtD
Ceftaroline fosamil—Pain—Gemcitabine—kidney cancer	0.00163	0.00163	CcSEcCtD
Ceftaroline fosamil—Constipation—Gemcitabine—kidney cancer	0.00163	0.00163	CcSEcCtD
Ceftaroline fosamil—Nausea—Erlotinib—kidney cancer	0.00163	0.00163	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Sunitinib—kidney cancer	0.00163	0.00163	CcSEcCtD
Ceftaroline fosamil—Erythema—Capecitabine—kidney cancer	0.00161	0.00161	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Capecitabine—kidney cancer	0.00161	0.00161	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Paclitaxel—kidney cancer	0.0016	0.0016	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Vincristine—kidney cancer	0.00159	0.00159	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Vincristine—kidney cancer	0.00159	0.00159	CcSEcCtD
Ceftaroline fosamil—Dizziness—Sunitinib—kidney cancer	0.00157	0.00157	CcSEcCtD
Ceftaroline fosamil—Vomiting—Sorafenib—kidney cancer	0.00157	0.00157	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Paclitaxel—kidney cancer	0.00157	0.00157	CcSEcCtD
Ceftaroline fosamil—Hypokalaemia—Doxorubicin—kidney cancer	0.00157	0.00157	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Paclitaxel—kidney cancer	0.00157	0.00157	CcSEcCtD
Ceftaroline fosamil—Rash—Sorafenib—kidney cancer	0.00156	0.00156	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Sorafenib—kidney cancer	0.00156	0.00156	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Paclitaxel—kidney cancer	0.00155	0.00155	CcSEcCtD
Ceftaroline fosamil—Headache—Sorafenib—kidney cancer	0.00155	0.00155	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Dactinomycin—kidney cancer	0.00154	0.00154	CcSEcCtD
Ceftaroline fosamil—Vomiting—Sunitinib—kidney cancer	0.00151	0.00151	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Gemcitabine—kidney cancer	0.00151	0.00151	CcSEcCtD
Ceftaroline fosamil—Rash—Sunitinib—kidney cancer	0.0015	0.0015	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Sunitinib—kidney cancer	0.0015	0.0015	CcSEcCtD
Ceftaroline fosamil—Headache—Sunitinib—kidney cancer	0.00149	0.00149	CcSEcCtD
Ceftaroline fosamil—Anaemia—Capecitabine—kidney cancer	0.00149	0.00149	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Vincristine—kidney cancer	0.00148	0.00148	CcSEcCtD
Ceftaroline fosamil—Eosinophilia—Doxorubicin—kidney cancer	0.00147	0.00147	CcSEcCtD
Ceftaroline fosamil—Nausea—Sorafenib—kidney cancer	0.00147	0.00147	CcSEcCtD
Ceftaroline fosamil—Vomiting—Dactinomycin—kidney cancer	0.00143	0.00143	CcSEcCtD
Ceftaroline fosamil—Palpitations—Capecitabine—kidney cancer	0.00142	0.00142	CcSEcCtD
Ceftaroline fosamil—Rash—Dactinomycin—kidney cancer	0.00142	0.00142	CcSEcCtD
Ceftaroline fosamil—Nausea—Sunitinib—kidney cancer	0.00141	0.00141	CcSEcCtD
Ceftaroline fosamil—Neutropenia—Doxorubicin—kidney cancer	0.00139	0.00139	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.00138	0.00138	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Vincristine—kidney cancer	0.00138	0.00138	CcSEcCtD
Ceftaroline fosamil—Pain—Paclitaxel—kidney cancer	0.00137	0.00137	CcSEcCtD
Ceftaroline fosamil—Constipation—Paclitaxel—kidney cancer	0.00137	0.00137	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.00136	0.00136	CcSEcCtD
Ceftaroline fosamil—Pruritus—Gemcitabine—kidney cancer	0.00135	0.00135	CcSEcCtD
Ceftaroline fosamil—Hyperglycaemia—Doxorubicin—kidney cancer	0.00134	0.00134	CcSEcCtD
Ceftaroline fosamil—Nausea—Dactinomycin—kidney cancer	0.00134	0.00134	CcSEcCtD
Ceftaroline fosamil—Dizziness—Vincristine—kidney cancer	0.00133	0.00133	CcSEcCtD
Ceftaroline fosamil—Infestation NOS—Doxorubicin—kidney cancer	0.00133	0.00133	CcSEcCtD
Ceftaroline fosamil—Infestation—Doxorubicin—kidney cancer	0.00133	0.00133	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Paclitaxel—kidney cancer	0.00131	0.00131	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Gemcitabine—kidney cancer	0.00131	0.00131	CcSEcCtD
Ceftaroline fosamil—Renal failure—Doxorubicin—kidney cancer	0.0013	0.0013	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Capecitabine—kidney cancer	0.00129	0.00129	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Capecitabine—kidney cancer	0.00129	0.00129	CcSEcCtD
Ceftaroline fosamil—Vomiting—Vincristine—kidney cancer	0.00128	0.00128	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Capecitabine—kidney cancer	0.00127	0.00127	CcSEcCtD
Ceftaroline fosamil—Urticaria—Paclitaxel—kidney cancer	0.00127	0.00127	CcSEcCtD
Ceftaroline fosamil—Rash—Vincristine—kidney cancer	0.00127	0.00127	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Vincristine—kidney cancer	0.00127	0.00127	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Paclitaxel—kidney cancer	0.00126	0.00126	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Paclitaxel—kidney cancer	0.00126	0.00126	CcSEcCtD
Ceftaroline fosamil—Headache—Vincristine—kidney cancer	0.00126	0.00126	CcSEcCtD
Ceftaroline fosamil—Hepatobiliary disease—Doxorubicin—kidney cancer	0.00125	0.00125	CcSEcCtD
Ceftaroline fosamil—Vomiting—Gemcitabine—kidney cancer	0.00121	0.00121	CcSEcCtD
Ceftaroline fosamil—Bradycardia—Doxorubicin—kidney cancer	0.00121	0.00121	CcSEcCtD
Ceftaroline fosamil—Rash—Gemcitabine—kidney cancer	0.0012	0.0012	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Gemcitabine—kidney cancer	0.0012	0.0012	CcSEcCtD
Ceftaroline fosamil—Headache—Gemcitabine—kidney cancer	0.0012	0.0012	CcSEcCtD
Ceftaroline fosamil—Nausea—Vincristine—kidney cancer	0.0012	0.0012	CcSEcCtD
Ceftaroline fosamil—Hepatitis—Doxorubicin—kidney cancer	0.00119	0.00119	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Paclitaxel—kidney cancer	0.00118	0.00118	CcSEcCtD
Ceftaroline fosamil—Urinary tract disorder—Doxorubicin—kidney cancer	0.00118	0.00118	CcSEcCtD
Ceftaroline fosamil—Urethral disorder—Doxorubicin—kidney cancer	0.00117	0.00117	CcSEcCtD
Ceftaroline fosamil—Nausea—Gemcitabine—kidney cancer	0.00113	0.00113	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Capecitabine—kidney cancer	0.00113	0.00113	CcSEcCtD
Ceftaroline fosamil—Pruritus—Paclitaxel—kidney cancer	0.00113	0.00113	CcSEcCtD
Ceftaroline fosamil—Pain—Capecitabine—kidney cancer	0.00112	0.00112	CcSEcCtD
Ceftaroline fosamil—Constipation—Capecitabine—kidney cancer	0.00112	0.00112	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Paclitaxel—kidney cancer	0.00109	0.00109	CcSEcCtD
Ceftaroline fosamil—Angiopathy—Doxorubicin—kidney cancer	0.00108	0.00108	CcSEcCtD
Ceftaroline fosamil—Immune system disorder—Doxorubicin—kidney cancer	0.00108	0.00108	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Capecitabine—kidney cancer	0.00107	0.00107	CcSEcCtD
Ceftaroline fosamil—Dizziness—Paclitaxel—kidney cancer	0.00106	0.00106	CcSEcCtD
Ceftaroline fosamil—Urticaria—Capecitabine—kidney cancer	0.00104	0.00104	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Capecitabine—kidney cancer	0.00104	0.00104	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Capecitabine—kidney cancer	0.00104	0.00104	CcSEcCtD
Ceftaroline fosamil—Erythema—Doxorubicin—kidney cancer	0.00104	0.00104	CcSEcCtD
Ceftaroline fosamil—Malnutrition—Doxorubicin—kidney cancer	0.00104	0.00104	CcSEcCtD
Ceftaroline fosamil—Vomiting—Paclitaxel—kidney cancer	0.00102	0.00102	CcSEcCtD
Ceftaroline fosamil—Rash—Paclitaxel—kidney cancer	0.00101	0.00101	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Paclitaxel—kidney cancer	0.00101	0.00101	CcSEcCtD
Ceftaroline fosamil—Headache—Paclitaxel—kidney cancer	0.001	0.001	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Capecitabine—kidney cancer	0.000967	0.000967	CcSEcCtD
Ceftaroline fosamil—Anaemia—Doxorubicin—kidney cancer	0.000958	0.000958	CcSEcCtD
Ceftaroline fosamil—Nausea—Paclitaxel—kidney cancer	0.00095	0.00095	CcSEcCtD
Ceftaroline fosamil—Pruritus—Capecitabine—kidney cancer	0.000929	0.000929	CcSEcCtD
Ceftaroline fosamil—Palpitations—Doxorubicin—kidney cancer	0.000916	0.000916	CcSEcCtD
Ceftaroline fosamil—Convulsion—Doxorubicin—kidney cancer	0.000898	0.000898	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Capecitabine—kidney cancer	0.000898	0.000898	CcSEcCtD
Ceftaroline fosamil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000877	0.000877	CcSEcCtD
Ceftaroline fosamil—Dizziness—Capecitabine—kidney cancer	0.000868	0.000868	CcSEcCtD
Ceftaroline fosamil—Anaphylactic shock—Doxorubicin—kidney cancer	0.000846	0.000846	CcSEcCtD
Ceftaroline fosamil—Vomiting—Capecitabine—kidney cancer	0.000835	0.000835	CcSEcCtD
Ceftaroline fosamil—Nervous system disorder—Doxorubicin—kidney cancer	0.00083	0.00083	CcSEcCtD
Ceftaroline fosamil—Thrombocytopenia—Doxorubicin—kidney cancer	0.000828	0.000828	CcSEcCtD
Ceftaroline fosamil—Rash—Capecitabine—kidney cancer	0.000828	0.000828	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Capecitabine—kidney cancer	0.000827	0.000827	CcSEcCtD
Ceftaroline fosamil—Headache—Capecitabine—kidney cancer	0.000822	0.000822	CcSEcCtD
Ceftaroline fosamil—Skin disorder—Doxorubicin—kidney cancer	0.000822	0.000822	CcSEcCtD
Ceftaroline fosamil—Nausea—Capecitabine—kidney cancer	0.00078	0.00078	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.00073	0.00073	CcSEcCtD
Ceftaroline fosamil—Pain—Doxorubicin—kidney cancer	0.000724	0.000724	CcSEcCtD
Ceftaroline fosamil—Constipation—Doxorubicin—kidney cancer	0.000724	0.000724	CcSEcCtD
Ceftaroline fosamil—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000692	0.000692	CcSEcCtD
Ceftaroline fosamil—Urticaria—Doxorubicin—kidney cancer	0.000672	0.000672	CcSEcCtD
Ceftaroline fosamil—Abdominal pain—Doxorubicin—kidney cancer	0.000669	0.000669	CcSEcCtD
Ceftaroline fosamil—Body temperature increased—Doxorubicin—kidney cancer	0.000669	0.000669	CcSEcCtD
Ceftaroline fosamil—Hypersensitivity—Doxorubicin—kidney cancer	0.000623	0.000623	CcSEcCtD
Ceftaroline fosamil—Pruritus—Doxorubicin—kidney cancer	0.000599	0.000599	CcSEcCtD
Ceftaroline fosamil—Diarrhoea—Doxorubicin—kidney cancer	0.000579	0.000579	CcSEcCtD
Ceftaroline fosamil—Dizziness—Doxorubicin—kidney cancer	0.00056	0.00056	CcSEcCtD
Ceftaroline fosamil—Vomiting—Doxorubicin—kidney cancer	0.000538	0.000538	CcSEcCtD
Ceftaroline fosamil—Rash—Doxorubicin—kidney cancer	0.000533	0.000533	CcSEcCtD
Ceftaroline fosamil—Dermatitis—Doxorubicin—kidney cancer	0.000533	0.000533	CcSEcCtD
Ceftaroline fosamil—Headache—Doxorubicin—kidney cancer	0.00053	0.00053	CcSEcCtD
Ceftaroline fosamil—Nausea—Doxorubicin—kidney cancer	0.000503	0.000503	CcSEcCtD
